Eric J Vick MD PhD (He/Him)
Hematology/Oncology
Hematology/Oncology Instructor at the University of Cincinnati
Join to View Full Profile
3188 Bellevue AveCincinnati, OH 45219
Phone+1 513-475-8500
Fax+1 513-245-3672
Dr. Vick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Physician Scientist
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2020 - 2023- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2018 - 2020
University of Tennessee Health Science Center College of MedicineClass of 2018, MD, Magna Cum Laude
Middle Tennessee State UniversityPh.D., Immunology, Summa Cum Laude, 2010 - 2014
Certifications & Licensure
OH State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Leukemia and Lymphoma Society Career Development Program Leukemia and Lymphoma Society, 2024
- ASCO Young Investigator Award American Society of Clinical Oncology, 2024
- Loan Repayment Program National Cancer Institute
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsInactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.Tomoya Muto, Callum S Walker, Puneet Agarwal, Eric Vick, Avery Sampson
Haematologica. 2023-10-01 - 9 citationsParalog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery Sampson
Blood. 2023-09-14 - 6 citationsImpact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients.Kate Clancy, Chelsea S. Hamill, W. Quinn O’Neill, Brandon Vu, Jason Thuener
Cancers. 2021-09-28
Press Mentions
Antibiotics May Reduce ICI EfficacyNovember 13th, 2020
University of Cincinnati Hematology Experts Present Research at National ConferenceDecember 12th, 2023
Professional Memberships
- American Society of HematologyMember
- American Society of Clinical OncologyMember
- American Medical AssociationMember
- American Association for Cancer ResearchMember
Industry Relationships
- Chief Scientific Officer, Salomon's House LLCInvestigate novel therapeutic leads from botanical sources by developing assays and testing leads in cancer, inflammation, and infection.Disclosure: None at this time2014 - 2020
External Links
- Researchgatehttps://www.researchgate.net/profile/Eric_Vick
- LinkedInhttps://www.linkedin.com/in/eric-vick-ph-d-8a65b038?trk=hp-identity-name
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
